Abstract
Life Science Analytics' , Gout Therapy Area Pipeline Report contains detailed
information on the allergy drug pipeline. This report provides insight into
the pipeline status of gout drugs by company and by stage as well as a summary
of the latest news and developments in this area.
Scope of the report:
Each Life Science Analytics’ Therapy Area Pipeline Report provides the
user with real detail on drug pipelines, by company and by stage, for each
specific therapy area. The latest news, by company, also ensures that each
report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each
report also contains extensive information in tabular format on a
company’s full product pipeline and products by phase of development
with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product
descriptions, information on partnering activity plus clinical trial
intelligence. Each Therapy Area Pipeline Report also provides detail on the
top 20 companies with products in the early stage of development and the top
20 companies with products in the late stage of development. Finally, each
report also provides a comparison with other major indications in the disease
hub based on Marketed Products vs. Pipeline Products.
Key benefits
* Understand a company’s strategic position by accessing detailed
independent intelligence on its product pipeline for specific therapy
areas.
* Keep track of your competitors and partners by better
understanding their product pipeline.
* Monitor a company’s
research effectiveness by determining pipeline depth and number of products in
development by clinical phase for specific disease areas.
* Maintain
a critical competitive advantage.
Table of Contents
Epidemiology Report
% of Products by Phase of Development
No. of
Products by Phase of Development
Marketed Products vs. Pipeline
Products
Company Overview - Pipeline Projects
Legend
--Top 5
Companies in Early Stage Gout Products
--Top 5 Companies in Late Stage
Gout Products
--Top 5 Companies in Marketed Gout Products
Upcoming
Milestones
Product Sales
Full Pipeline View
--Product Details :
Pre Clinical
--Product Details : Phase I
--Product Details : Phase
II
--Product Details : Phase III
--Product Details : Pending
Approval
--Product Details : Approved
--Product Details : On the
Market
News Updates
--Product Updates
--Regulatory
Gout Therapy Area Pipeline Report published by Life Science Analytics in March 14, 2011. This report consists of Pages: 198 and the price starts from US $ 1495.
The contents of this page may be different from the latest version. Please contact us for details.
